Researchers at the Riken Center for Integrative Medical Sciences in Japan found that a protein called HCK may help prevent the recurrence of acute myeloid leukemia. The researchers tested thousands of molecules and isolated one molecule activated against the cells that cause the relapse, according to findings published in Science Translational Medicine. Researchers said tests on a mouse model showed the molecule can reduce AML cells in the blood and bone marrow, but more research is needed before it can be administered to humans.

Related Summaries